These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4139303)

  • 1. [Antithrombotic action of nicotinic acid].
    Baluda VP; Eristavi ZA; Sushkevich GN
    Kardiologiia; 1974 Nov; 14(11):105-7. PubMed ID: 4139303
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of polysulfonate derivative (GL 2021) on coagulation in vitro and thrombosis in vivo.
    Radziwon P; Schenk J; Boczkowska-Radziwon B; Wojtukiewicz MZ; Giedrojc J; Kloczko J; Breddin HK
    Thromb Res; 2000 Jul; 99(1):99-104. PubMed ID: 10904107
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions.
    Turazza G; Spreafico PL; Frandoli G
    Arzneimittelforschung; 1973 May; 23(5):654-7. PubMed ID: 4575777
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic Drugs-Pharmacology and Perspectives.
    Li T; Yuan D; Yuan J
    Adv Exp Med Biol; 2020; 1177():101-131. PubMed ID: 32246445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the coagulation and fibrinolytic systems predisposing to thrombosis.
    Nilsson IM
    Acta Chir Scand Suppl; 1968; 387():15-22. PubMed ID: 4240349
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of heparin in the process of blood coagulation and fibrinolysis].
    Liapina LA
    Usp Sovrem Biol; 1977; 84(3):338-52. PubMed ID: 343416
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of the platelet-dependent fibrin retraction by the fibrin stabilizing factor (FSF, factor 13).
    Niewiarowski S; Markiewicz M; Nath N
    J Lab Clin Med; 1973 May; 81(5):641-50. PubMed ID: 4698655
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of troxerutin on laser-induced thrombus formation in rat mesenteric vessels, coagulation parameters and platelet function.
    Krupiński K; Giedrojć J; Bielawiec M
    Pol J Pharmacol; 1996; 48(3):335-9. PubMed ID: 9112673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of thrombotic diseases.
    Douglas AS
    Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions.
    Hamada M; Sugimoto M; Matsui H; Mizuno T; Shida Y; Doi M; Fukushima H; Nishio K; Yoshioka A; Shima M
    Thromb Haemost; 2011 Feb; 105(2):313-20. PubMed ID: 21136018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinolytic action of Complamin (R). Preliminary report].
    Harel P; Gauthier J
    Union Med Can; 1966 May; 95(5):542-5. PubMed ID: 5932651
    [No Abstract]   [Full Text] [Related]  

  • 12. [The antithrombotic and thrombolytic activity of tuftsin].
    Liapina LA; Pastorova VE; Kondashevskaia MV; Kudriashov BA; Kalikhevich VN; Kamenskiĭ AA; Ashmarin IP
    Biull Eksp Biol Med; 1993 Nov; 116(11):451-2. PubMed ID: 8312523
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of carbenicillin on the haemostatic mechanism.
    Lederer DA; Davies T; Connell G; Davies JA; McNicol GP
    J Pharm Pharmacol; 1973 Nov; 25(11):876-80. PubMed ID: 4149650
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrin-stabilizing factor inhibitors. 4. Action of some synthetic fibrinoligase inhibitors on human platelet aggregation.
    Lundén R; Hartkoorn A; Nilsson JL; Stenberg P; Bruner-Lorand J; Lorand L
    J Med Chem; 1972 Jan; 15(1):98-9. PubMed ID: 5007105
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum lipids following experimental fibrinolysis].
    Suschke J; Kunze D; von Pilar CE; Krejci K
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):388-9. PubMed ID: 4270871
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Mechanism of the antithrombotic action of dextran.
    Evans RJ; Gordon JL
    N Engl J Med; 1974 Mar; 290(13):748. PubMed ID: 4813751
    [No Abstract]   [Full Text] [Related]  

  • 17. Spirulan from blue-green algae inhibits fibrin and blood clots: its potent antithrombotic effects.
    Choi JH; Kim S; Kim SJ
    J Biochem Mol Toxicol; 2015 May; 29(5):240-8. PubMed ID: 25651404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vasoactive drugs and cerebral circulation].
    Pratesi F; Corsi C; Tesi M; Spinelli P; Brunetti S; Caramelli L
    Minerva Med; 1968 Dec; 59(96):5207-17. PubMed ID: 4974813
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental data on the effect of fibrinolysin on coronary circulation].
    Ponomareva AG; Zhdanov IuE; Zaĭtsev II; Gorokhov NS
    Biull Eksp Biol Med; 1966 May; 61(5):24-6. PubMed ID: 4236076
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the cardiovascular system of rabbits in diabetes and following the administration of various hormones].
    Lanin LE
    Biull Eksp Biol Med; 1969 Feb; 67(2):28-31. PubMed ID: 5821424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.